Duez Hélène, van der Veen Jelske N, Duhem Christian, Pourcet Benoît, Touvier Thierry, Fontaine Coralie, Derudas Bruno, Baugé Eric, Havinga Rick, Bloks Vincent W, Wolters Henk, van der Sluijs Fjodor H, Vennström Björn, Kuipers Folkert, Staels Bart
Institut Pasteur de Lille, Département d'Athérosclérose, Lille, France; Inserm, U545, Lille, France.
Gastroenterology. 2008 Aug;135(2):689-98. doi: 10.1053/j.gastro.2008.05.035. Epub 2008 May 15.
BACKGROUND & AIMS: Conversion into bile acids represents an important route to remove excess cholesterol from the body. Rev-erbalpha is a nuclear receptor that participates as one of the clock genes in the control of circadian rhythmicity and plays a regulatory role in lipid metabolism and adipogenesis. Here, we investigate a potential role for Rev-erbalpha in the control of bile acid metabolism via the regulation of the neutral bile acid synthesis pathway.
Bile acid synthesis and CYP7A1 gene expression were studied in vitro and in vivo in mice deficient for or over expressing Rev-erbalpha.
Rev-erbalpha-deficient mice display a lower synthesis rate and an impaired excretion of bile acids into the bile and feces. Expression of CYP7A1, the rate-limiting enzyme of the neutral pathway, is decreased in livers of Rev-erbalpha-deficient mice, whereas adenovirus-mediated hepatic Rev-erbalpha overexpression induces its expression. Moreover, bile acid feeding resulted in a more pronounced suppression of hepatic CYP7A1 expression in Rev-erbalpha-deficient mice. Hepatic expression of E4BP4 and the orphan nuclear receptor small heterodimer partner (SHP), both negative regulators of CYP7A1 expression, is increased in Rev-erbalpha-deficient mice. Promoter analysis and chromatin immunoprecipitation experiments demonstrated that SHP and E4BP4 are direct Rev-erbalpha target genes. Finally, the circadian rhythms of liver CYP7A1, SHP, and E4BP4 messenger RNA levels were perturbed in Rev-erbalpha-deficient mice.
These data identify a role for Rev-erbalpha in the regulatory loop of bile acid synthesis, likely acting by regulating both hepatic SHP and E4BP4 expression.
转化为胆汁酸是机体清除多余胆固醇的重要途径。Rev-erbalpha是一种核受体,作为生物钟基因之一参与昼夜节律的调控,并在脂质代谢和脂肪生成中发挥调节作用。在此,我们研究Rev-erbalpha通过调节中性胆汁酸合成途径在胆汁酸代谢控制中的潜在作用。
在Rev-erbalpha基因缺失或过表达的小鼠体内及体外研究胆汁酸合成及CYP7A1基因表达。
Rev-erbalpha基因缺失的小鼠胆汁酸合成速率较低,胆汁和粪便中胆汁酸排泄受损。中性途径的限速酶CYP7A1在Rev-erbalpha基因缺失小鼠肝脏中的表达降低,而腺病毒介导的肝脏Rev-erbalpha过表达可诱导其表达。此外,给予胆汁酸后,Rev-erbalpha基因缺失小鼠肝脏中CYP7A1表达的抑制更为明显。CYP7A1表达的负调节因子E4BP4和孤儿核受体小异源二聚体伴侣(SHP)在Rev-erbalpha基因缺失小鼠肝脏中的表达增加。启动子分析和染色质免疫沉淀实验表明,SHP和E4BP4是Rev-erbalpha的直接靶基因。最后,Rev-erbalpha基因缺失小鼠肝脏中CYP7A1、SHP和E4BP4信使RNA水平的昼夜节律受到干扰。
这些数据确定了Rev-erbalpha在胆汁酸合成调节环中的作用,可能是通过调节肝脏中SHP和E4BP4的表达来发挥作用。